Citra-Lock™ S

Catheter lock solution, anti-clotting and antimicrobial is one of
the innovations from Dirinco

Citra-Lock™ is recommended in the European Renal Best Practice
Guidelines (ERBP) and the American Society of Diagnostic and
Interventional Nephrology (ASDIN).

• Citra locks have been extensively studied.
• Citra-Lock™ is effective in maintaining catheter patency.

Clinical advantage of Citra-Lock™

• safe
• avoids heparin-associated bleeding
• improves reliability of INR assyas (prothrombin time – time/international normalised ratio)
• safe for heparin induced thrombocytopenia (HIT patients)
• no side effects
• reduction of tPA use
• better outcomes over catheter exchange
• reduces biofilm
• reduction of hospitalisation
• cost efficient

 The Citrate lock is based on tri-sodium citrate and can be safely
used in all catheters!

• Citra-Lock™ 5ml vials 4% – 30% -46,7%
• Citra-Lock™S 3ml (prefilled syringe) 4% – 30% -46,7%

 Citra-Lock™S prefilled syringe
Citra-Lock™ 4%      *Twin-Pack  Art.nr. 24060204
Citra-Lock™ 30%    *Twin-Pack  Art.nr. 24060205
Citra-Lock™ 46,7% *Twin-Pack  Art.nr. 24060206
*2x 2.5ml